Singapore
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.70 B |
Jan. 14, 2025 | USD 11.13 | -1.24% |
|
Singapore |
The Clinical Trials company in Singapore with the highest Market Capitalization is Wave Life Sciences Ltd. (NasdaqGM: WVE) at USD 1.70 B.
The Clinical Trials company in Singapore with the lowest Market Capitalization is Wave Life Sciences Ltd. (NasdaqGM: WVE) at USD 1.70 B.
The top 10 Clinical Trials companies in Singapore by Market Capitalization are and Wave Life Sciences Ltd..
The bottom 10 Clinical Trials companies in Singapore by Market Capitalization are and Wave Life Sciences Ltd..